Who we are

VI.REL Pharma was founded in 1997 as a specialized consulting firm in the field of drug R&D. Today, the VI.REL group consists of VI.REL Pharma, an AIC-holding company in Italy and other European countries, and the VI.REL Consulting division, which specializes in consulting services in regulatory affairs, medical writing and pharmacovigilance.

In November 2021 VI.REL Pharma obtained ISO 9001:2015 certification (Registration Number: IT-130536) for the following activities: Consulting in Regulatory Affairs, Pharmacosurveillance Activities and Medical Writing.

Paolo Biffignandi

Scientific Director, Senior Medical Writing, QPPV. Physician specializing in endocrinology and pharmacology at the University of Turin. After graduation, he carried out several years of teaching…

Lorella Carletto

Regulatory Officer, Deputy QPPV. Bachelor’s degree in biological sciences from the University of Turin. He has served as Chief Scientific Officer at Studio Barberis…

Virginia Biffignandi

Safety Officer, Quality Assurance. Bachelor’s degree in biological sciences from the University of Turin. He participated in training courses regarding Pharmacovigilance organized by SIAR…

Claudia Moia

Regulatory Affairs Assistant. Graduated in Industrial Biotechnology from the University of Pavia. He obtained a PhD in Nanomedicine from Cranfield University (UK)…

Roberta Pace

Pharmacovigilance Assistant. Degree in Pharmacy from the University of Palermo. He attended the master’s program in Pharmaceutical Technologies and Regulatory Activities…

Krystian Krysinski

Pharmacovigilance Specialist and Deputy QPPV. Graduate in Pharmaceutical Chemistry and Technology from the University of Bologna. Pharmacist with long experience in the UK.

Paolo Biffignandi

Scientific Director, Senior Medical Writing, QPPV.

Physician specializing in endocrinology and pharmacology at the University of Turin. After graduation, he spent several years teaching at the same university and received an appointment as assistant professor in the Department of Internal Medicine at St. Louis Hospital in Turin. In 1990, he embarked on a career as a pharmaceutical physician until founding VI.REL Pharma in 1997 in response to increased demand from pharmaceutical companies for expertise in regulatory affairs and clinical development. Paolo Biffignandi has authored more than 160 scientific articles in endocrinology, general medicine, diabetology, pharmacology, nutraceuticals and regulatory affairs. As an invited speaker, he has participated in major international symposia on European drug legislation. He is a member of the most prestigious European societies in the field including AFI, SIAR in Italy and EMWA, RAPS, DIA and TOPRA internationally. He was Editor-in-Chief of TOPRA Rapporteur, a member of the Board of Directors of TOPRA from 2004 to 2011 and President from 2009 to 2011.

Lorella Carletto

Regulatory Officer, Deputy QPPV

Bachelor’s degree in biological sciences from the University of Turin. He has served as Chief Scientific Officer at Studio Barberis, Kelemata Research Laboratory and Delalande Laboratories in Turin, Italy. In 1989 she co-founded with Paolo Biffignandi Pharmacon in which she served as Vice President and Quality Manager. In 1997 he co-founded VI.REL Pharma with Paolo Biffignandi, of which he is vice-president. From 2005 to 2010, she was a consultant for Regulatory Affairs for Procemsa Pharmaceuticals. n a consulting capacity, he has worked with major national and international pharmaceutical companies. He has been a member of AFI since 2010. He has been a member of the Pharmacovigilance group of Farmindustria since 2012 and also of the Inspections subgroup since 2016. He has been a member of SFFA since 2016.

Virginia Biffignandi

Safety Officer, Quality Assurance

Bachelor’s degree in biological sciences from the University of Turin. He participated in training courses regarding Pharmacovigilance organized by SIAR, EMA, TEMAS and Farmindustria. In 2014, she joined VI.REL Pharma in the role of Safety Officer.

He has been a member of SFFA since 2016.

In January 2021, she became the QA of VI.REL Pharma.

Claudia Moia

Regulatory Affairs Assistant

Graduated in Industrial Biotechnology from the University of Pavia. He received a PhD in Nanomedicine from Cranfield University (UK) and a master’s degree in Pharmaceutical Technologies and Regulatory Activities from University of Turin. She has been a Project researcher at San Raffaele Scientific Institute and a Fellow at University of Pavia. He has been a member of the British Toxicology Society (BTS) since 2013 and a member of AFI since 2021. In 2021, he joined VI.REL Pharma through curricular internship; since March 2022, he has held the position of Regulatory Affairs Assistant.

Roberta Pace

Pharmacovigilance Assistant

Degree in Pharmacy from the University of Palermo. He attended the master’s program in Pharmaceutical Technologies and Regulatory Activities at the University of Turin. He has been a member of AFI since 2021. In 2021 he joined VI.REL Pharma through curricular internship; since March 2022 he has held the position of Pharmacovigilance Assistant.

Krystian Krysinski

Pharmacovigilance Specialist and Deputy QPPV

Graduate in Pharmaceutical Chemistry and Technology from the University of Bologna. Pharmacist with long experience in the UK. In January 2021, he joins the staff of VI.REL Pharma: he is responsible for managing daily and strategic pharmacovigilance activities.